Wikipedia -WSS

Wikipedia

author：fashion 2025-09-27 12:48:13 - browse：627

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： ASCO: Palliative care found as helpful given virtually as in person

WSS

How should state employee insurance handle Wegovy?

How to increase colonoscopy rates? Looks like an AI can help

How to increase colonoscopy rates? Looks like an AI can help

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

FDA's Pazdur wants cancer trials to range beyond China alone

Female surgeons have lower rates of long

hotspot

Wikipedia

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

Letters to First Opinion on caregivers, digital health, and more

Medical leaders decry Supreme Court decision on affirmative action

How clinical AI models' predictive power can degrade over time

23andMe had bad news about my health. I wish a person had delivered it

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

In age of alternative facts, a scholarly course on calling out crap

Medicare to cover more brain scans related to Alzheimer’s drugs

Walensky prepares to leave CDC — and Congress — behind

Change Healthcare can notify patients about the breach, HHS says

entertainment

A fraught question for the kids of Alzheimer’s: Is it coming for us?

There’s no way to know how good AI health technologies are

Takeaways from AdvaMed, the largest medical devices conference

Cord blood banking comes at a high cost to babies

Ultragenyx gene therapy for rare liver ailment succeeds in late

Let's speed up science by embracing open access publishing

Wikipedia

hotspot

entertainment

hotspot